Chad Billingsley To Miss Season
Near the end of last season there was a decision to be made whether Billinsgley would have Tommy John Surgery. The other option was getting prp (platelet-rich plasma) injections that could possibly prevent the need from surgery to ever take place. The injections were a known risk to both Billingsley and the Dodgers and one they obviously decided was worth taking.
Some, including myself, speculated why the Dodgers would take a risk on the injections that seemed to be a bandage to not prevent, but rather, prolong the inevitable surgery. Now instead of missing just the 2013 season, Billingsley will miss a good portion of next season before he is at full strength. It’s certainly easy for one to say that now given the risk didn’t pay off for either side.
The Dodgers rotation has already seen it’s fair share of injuries with Zack Greinke (Collarbone) and Chris Capuano (Calf) on the shelf. Ted Lilly, who is just coming off his own injury, will make his first start of the year on Wednesday. With the trade of Aaron Harang a couple weeks ago, this means that the original number of eight starters the Dodgers had heading into spring training has been whittled down to 4.
The most recent injury to Billingsley is a prime example of why Dodgers GM Ned Colletti kept most of them. The rotation is now set as Clayton Kershaw, Lilly, Hyun-jin Ryu, Josh Beckett, and a fifth starter of Stephen Fife when needed.
If Lilly can stay healthy the Dodgers starting five will be just fine when they get Greinke back and their offense wakes up, but today’s news is without a doubt disconcerting.